The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Heritage: A phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin.
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech
 
Abhijit Barve
Employment - Biocon; Mylan
Leadership - Biocon; Mylan
Stock and Other Ownership Interests - Biocon; Mylan
 
Cornelius F. Waller
Consulting or Advisory Role - Mylan
 
Miguel Hernandez-Bronchud
Employment - Quironsalud
Honoraria - Mylan
Consulting or Advisory Role - Mylan
Patents, Royalties, Other Intellectual Property - Self
 
Jay Herson
Consulting or Advisory Role - Celgene
 
Jinyu Yuan
Employment - Mylan
Stock and Other Ownership Interests - Mylan
Consulting or Advisory Role - Mylan
Travel, Accommodations, Expenses - Mylan
 
Alexey Manikhas
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Guzel Mukhametshina
No Relationships to Disclose
 
Gia Nemsadze
No Relationships to Disclose
 
Joseph D. Parra
No Relationships to Disclose
 
Maria Luisa T. Abesamis Tiambeng
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Roche
Speakers' Bureau - Boehringer Ingelheim; MSD; Roche
Research Funding - AB Science; Amgen; Celltrion; Mylan; Pfizer; Roche
Travel, Accommodations, Expenses - Merck Serono
 
Kakhaber Baramidze
No Relationships to Disclose
 
Charuwan Akewanlop
Research Funding - Mylan; Roche
Travel, Accommodations, Expenses - Eisai; Novartis
 
Ihor Vynnychenko
No Relationships to Disclose
 
Virote Sriuranpong
No Relationships to Disclose
 
Gopichand Manillapalli
No Relationships to Disclose
 
Sirshendu Ray
No Relationships to Disclose
 
Eduardo Patricio Yanez Ruiz
No Relationships to Disclose
 
Eduardo J. Pennella
Employment - Mylan
Stock and Other Ownership Interests - Mylan